Correlation Between Legend Biotech and Arcutis Biotherapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Legend Biotech and Arcutis Biotherapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Legend Biotech and Arcutis Biotherapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Legend Biotech Corp and Arcutis Biotherapeutics, you can compare the effects of market volatilities on Legend Biotech and Arcutis Biotherapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Legend Biotech with a short position of Arcutis Biotherapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Legend Biotech and Arcutis Biotherapeutics.

Diversification Opportunities for Legend Biotech and Arcutis Biotherapeutics

0.3
  Correlation Coefficient

Weak diversification

The 3 months correlation between Legend and Arcutis is 0.3. Overlapping area represents the amount of risk that can be diversified away by holding Legend Biotech Corp and Arcutis Biotherapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Arcutis Biotherapeutics and Legend Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Legend Biotech Corp are associated (or correlated) with Arcutis Biotherapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Arcutis Biotherapeutics has no effect on the direction of Legend Biotech i.e., Legend Biotech and Arcutis Biotherapeutics go up and down completely randomly.

Pair Corralation between Legend Biotech and Arcutis Biotherapeutics

Given the investment horizon of 90 days Legend Biotech Corp is expected to under-perform the Arcutis Biotherapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Legend Biotech Corp is 1.53 times less risky than Arcutis Biotherapeutics. The stock trades about -0.06 of its potential returns per unit of risk. The Arcutis Biotherapeutics is currently generating about 0.37 of returns per unit of risk over similar time horizon. If you would invest  852.00  in Arcutis Biotherapeutics on August 31, 2024 and sell it today you would earn a total of  319.00  from holding Arcutis Biotherapeutics or generate 37.44% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy95.65%
ValuesDaily Returns

Legend Biotech Corp  vs.  Arcutis Biotherapeutics

 Performance 
       Timeline  
Legend Biotech Corp 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Legend Biotech Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's technical and fundamental indicators remain very healthy which may send shares a bit higher in December 2024. The recent disarray may also be a sign of long period up-swing for the firm investors.
Arcutis Biotherapeutics 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Arcutis Biotherapeutics are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unfluctuating basic indicators, Arcutis Biotherapeutics unveiled solid returns over the last few months and may actually be approaching a breakup point.

Legend Biotech and Arcutis Biotherapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Legend Biotech and Arcutis Biotherapeutics

The main advantage of trading using opposite Legend Biotech and Arcutis Biotherapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Legend Biotech position performs unexpectedly, Arcutis Biotherapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Arcutis Biotherapeutics will offset losses from the drop in Arcutis Biotherapeutics' long position.
The idea behind Legend Biotech Corp and Arcutis Biotherapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.

Other Complementary Tools

Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences